Related Experiment Video
Updated: Apr 20, 2026

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms
Published on: April 17, 2026
Gastric Invasive Micropapillary Carcinoma with Intestinal Phenotypes Harboring a TP53 R175H Mutation
Hideyuki Ikeda1, Takehiro Kukitsu2, Wataru Johmen3
1Divisions of Surgical Pathology, Rumoi City Hospital, Rumoi, Japan.
Abstract:
We report a case of gastric invasive micropapillary carcinoma (IMPC) in an 86-year-old female patient. She was admitted to our hospital with a chief complaint of bloody emesis. Upper gastrointestinal endoscopy found a gastric adenocarcinoma at the antrum. The biopsy specimens showed moderately differentiated adenocarcinoma with invasive small tumor nests. Distal gastrectomy with systematic lymph node dissection demonstrated that the tumor had IMPC through a pathological examination. Despite the depth of tumor invasion (the submucosa), extensive lymph node metastases were observed. Anti-D2-40 immunostaining revealed numerous infiltrating tumor cell nests in the lymphatic vessels, which could explain subsequent multiple lymph node metastases. The adenocarcinoma showed intestinal phenotypes by several immunohistochemical studies. One of these antibodies (CD10) clearly demonstrated the inverted apical-basal (inside-out) pattern of IMPC, whereas it showed an ordinary pattern in intestinal metaplasia adjacent to the tumor. Furthermore, genetic analysis by direct sequencing revealed a point mutation in the exon 5 of TP53 in the tumor. The mutation presumably harbors a missense mutation from Arg to His at the codon 175 (R175H). R175H has been previously described as a 'gain-of-function' mutation with a high invasive or metastatic potential in several types of cancers. In summary, this is one of the first reported cases of gastric IMPC with intestinal phenotypes harboring a TP53 R175H mutation in the literature.
Insights
This case study highlights gastric invasive micropapillary carcinoma (IMPC), a rare subtype of gastric cancer. The study identifies a TP53 R175H mutation, linked to increased cancer invasiveness and metastasis.
Area of Science:
- Gastroenterology
- Oncology
- Pathology
Background:
- Gastric invasive micropapillary carcinoma (IMPC) is a rare and aggressive subtype of gastric adenocarcinoma.
- Early diagnosis and understanding of its behavior are crucial for patient outcomes.
Observation:
- An 86-year-old female presented with bloody emesis, diagnosed with gastric adenocarcinoma.
- Pathological examination revealed invasive micropapillary carcinoma with submucosal invasion and extensive lymph node metastases.
- Immunohistochemical staining (D2-40 and CD10) confirmed IMPC features and lymphatic vessel invasion.
Findings:
- The gastric IMPC exhibited intestinal phenotypes.
- A TP53 gene mutation (R175H) was identified, a known 'gain-of-function' mutation associated with high metastatic potential.
- CD10 staining demonstrated the characteristic inverted apical-basal pattern of IMPC.
Implications:
- This case provides insights into the clinicopathological and molecular characteristics of gastric IMPC.
- The TP53 R175H mutation may contribute to the aggressive behavior and metastasis observed in this patient.
- Further research into gastric IMPC with intestinal phenotypes and specific mutations is warranted.
Related Concept Videos
Gastritis II: Pathophysiology
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

